Compound_ID	Active	Smiles	canonical_smi	Set	Set_type	MW	HBD	HBA	NRB	NR	NAR	PSA	Standard Type	Standard Relation	Standard Units	Standard Value	Assay ChEMBL ID	Assay Description	BAO Label
CHEMBL3642368	1.0	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc5c(c4)CCC(N4CCOCC4)CC5)nc23)cc1	CS(=O)(=O)c1ccc(-c2cccn3nc(Nc4ccc5c(c4)CCC(N4CCOCC4)CC5)nc23)cc1	G2 active	External	517.66	1	7	5	6	4	88.83	IC50	'='	nM	1.55	CHEMBL3707950	In Vitro Enzyme Assay: The ability of compounds to inhibit the kinase activity of baculovirus-expressed human FAK and JAK kinase using the time-resolved fluorescence (TRF) assay system.	single protein format
CHEMBL3702962	1.0	[C-]#[N+]C1=CCC[C@@H](OCC2CC2)C1	[C-]#[N+]C1=CCC[C@@H](OCC2CC2)C1	G2 active	External	177.25	0	1	3	2	0	13.59	IC50	'='	nM	74.0	CHEMBL3707623	HTRF Assay: The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAK1 #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 mL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer #PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at ambient temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction.	single protein format
CHEMBL3116060	1.0	COc1ccc2c(Nc3cn(C)cn3)nc(NC(C)c3ncc(F)cn3)nc2c1	COc1ccc2c(Nc3cn(C)cn3)nc(NC(C)c3ncc(F)cn3)nc2c1	G2 active	External	394.41	2	8	6	4	4	102.67	IC50	'='	nM	24.0	CHEMBL3118240	Inhibition of Jak2 (unknown origin)	single protein format
CHEMBL3651056	1.0	COC(=O)Cc1ccc(OC)c(-c2c[nH]c3ncnc(-c4ccccc4)c23)c1	COC(=O)Cc1ccc(OC)c(-c2c[nH]c3ncnc(-c4ccccc4)c23)c1	G2 active	External	373.41	1	5	5	4	4	77.1	IC50	'='	nM	93.0	CHEMBL3707801	HTRF Assay: The ability of compounds to inhibit the activity of JAKl, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAKl #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384- well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser.Subsequent reagent additions employed an Agilent Bravo. Next, 18 of 1.1 IX enzyme and 1.1 IX substrate in IX assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 \xL of 10X ATP in IX assay buffer was added to initiate the kinase reaction and the plates were shaken.	single protein format
CHEMBL569948	1.0	CCCN(CCC)c1cc(-c2c(N)nn3cccnc23)ncn1	CCCN(CCC)c1cc(-c2c(N)nn3cccnc23)ncn1	G2 active	External	311.39	1	6	6	3	3	85.23	IC50	'='	nM	25.0	CHEMBL1044318	Inhibition of JAK2 by radiometric assay	single protein format
CHEMBL3765517	1.0	CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O	CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O	G2 active	External	433.54	2	7	4	4	3	131.9	IC50	'='	nM	13.0	CHEMBL3766653	Inhibition of JAK2 (unknown origin) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay	single protein format
CHEMBL3216659	1.0	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1	G2 active	External	468.36	3	5	4	5	2	77.99	IC50	'='	nM	224.0	CHEMBL4042012	Inhibition of recombinant JAK2 (unknown origin) after 120 mins in presence of [33P]ATP	single protein format
CHEMBL3909449	1.0	N#CCC1(n2cc(C(N)=O)c(Nc3ccc(F)cc3)n2)CCN(Cc2cccc3[nH]ccc23)CC1	N#CCC1(n2cc(C(N)=O)c(Nc3ccc(F)cc3)n2)CCN(Cc2cccc3[nH]ccc23)CC1	G2 active	External	471.54	3	5	7	5	4	115.76	IC50	'='	nM	280.0	CHEMBL3888429	HTRF Biochemical Assay: The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 nL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer # PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at room temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction and the plates were shaken and then incubated at room temperature for 120 minutes. At the end of the incubation, 20 uL of 2x stop buffer (streptavidin-Dylight 650 (Thermo #84547B/100 mL), Eu-tagged pY20 antibody (Perkin Elmer #AD0067), EDTA, HEPES, and Triton) was added to quench the reaction.	single protein format
CHEMBL4075131	1.0	Cn1c(-c2c(Cl)cccc2Cl)nc2c(NC(=O)C3CC3)nccc21	Cn1c(-c2c(Cl)cccc2Cl)nc2c(NC(=O)C3CC3)nccc21	G2 active	External	361.23	1	3	3	4	3	59.81	Ki	'='	nM	130.0	CHEMBL4046590	Inhibition of JAK2 (unknown origin) by biochemical assay	single protein format
CHEMBL1164180	1.0	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1	G2 active	External	502.97	1	6	4	5	3	47.53	Inhibition	'='	%	94.0	CHEMBL1166033	Inhibition of JAK2 JH1 catalytic domain at 1 uM	single protein format
CHEMBL1946839	1.0	C/C(=C(/C)c1ccc(CN(C)C)c(O)c1)c1ccc(CN(C)C)c(O)c1	C/C(=C(/C)c1ccc(CN(C)C)c(O)c1)c1ccc(CN(C)C)c(O)c1	G2 active	External	354.49	2	4	6	2	2	46.94	Inhibition	'='	%	101.13	CHEMBL1947612	Inhibition of Jak2 autophosphorylation at 2.5 uM after 30 mins by Western blot analysis relative to control	single protein format
CHEMBL3645544	0.0	O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C1CC1	O=C(Nc1cccc(-c2cnc3ccccc3n2)c1)C1CC1	G2 inactive	External	289.34	1	3	3	4	3	54.88	IC50	'='	nM	25000.0	CHEMBL3707587	In Vitro Kinase Enzyme Assay: In vitro kinase enzyme assay using Jak3, Jak2, Jak1, and Tyk2.	single protein format
CHEMBL1448	0.0	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O	G2 inactive	External	327.12	2	4	3	2	2	92.47	IC50	'='	nM	10000.0	CHEMBL1696959	Inhibition of JAK2	single protein format
CHEMBL4632980	0.0	Cc1[nH]nc2[nH]c(=O)c(C#N)c(C3CCCCC3)c12	Cc1[nH]nc2[nH]c(=O)c(C#N)c(C3CCCCC3)c12	G2 inactive	External	256.31	2	3	1	3	2	85.33	IC50	'='	nM	17000.0	CHEMBL4612622	Inhibition of N-terminal His-tagged human JAK2 catalytic domain incubated for 20 mins in presence of TK substrate-biotin by TR-FRET assay	single protein format
CHEMBL4097600	0.0	Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCNC(=O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)OP(=O)(O)OP(=O)(O)O)=[N+]1[B-]2(F)F	Cc1cc(C)n2c1C=C1C=CC(CCC(=O)NCCNC(=O)O[C@@H]3[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O[C@@H](n4cnc5c(N)ncnc54)[C@@H]3O)=[N+]1[B-]2(F)F	G2 inactive	External	867.36	8	19	15	6	3	334.27	Kd	'='	nM	7000.0	CHEMBL4022638	Binding affinity to wild type JAK2 JH2 domain (unknown origin) by competitive fluorescence polarization assay	single protein format
CHEMBL2029696	0.0	O=C1NN(c2ccc(F)cc2)C(=O)/C1=C\c1cccc(OCc2ccccc2F)c1	O=C1NN(c2ccc(F)cc2)C(=O)/C1=C\c1cccc(OCc2ccccc2F)c1	G2 inactive	External	406.39	1	3	5	4	3	58.64	Inhibition	'='	%	22.0	CHEMBL3119787	Inhibition of JAK2 (unknown origin) at 20 uM by radioactive ATP method	single protein format
CHEMBL5081774	0.0	[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1	[2H]C([2H])([2H])C1(C([2H])([2H])[2H])Cn2nc(-c3ccc(F)cn3)c(-c3ccnc4[nH]ncc34)c2CO1	G2 inactive	External	370.42	1	5	4	5	4	81.51	Inhibition	'='	%	1.0	CHEMBL5059169	JAK2(h) Kinase panel	single protein format
CHEMBL156524	0.0	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1	G2 inactive	External	324.77	1	3	2	4	2	49.41	Inhibition	'='	%	2.17	CHEMBL1962119	GSK_PKIS: JAK2 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1794071	0.0	ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21	ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21	G2 inactive	External	373.46	3	4	3	5	3	86.19	Inhibition	'='	%	0.14	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL187985	0.0	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21	G2 inactive	External	299.34	1	7	3	4	3	98.89	Inhibition	'='	%	-1.12	CHEMBL1962119	GSK_PKIS: JAK2 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL1909342	0.0	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2	G2 inactive	External	305.4	1	4	3	3	1	65.36	Inhibition	'='	%	2.82	CHEMBL1962119	GSK_PKIS: JAK2 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL204934	0.0	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1	G2 inactive	External	345.37	1	6	5	4	4	90.11	Inhibition	'='	%	0.32	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL218088	0.0	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1	G2 inactive	External	268.32	2	3	3	2	2	76.21	Inhibition	'='	%	2.62	CHEMBL1962119	GSK_PKIS: JAK2 mean inhibition at 1 uM [Nanosyn]	single protein format
CHEMBL269985	0.0	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1	G2 inactive	External	413.48	1	5	6	4	4	77.25	Inhibition	'='	%	1.32	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL30432	0.0	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1	G2 inactive	External	395.47	1	6	5	5	5	71.76	Inhibition	'='	%	1.55	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL379300	0.0	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12	G2 inactive	External	397.48	3	4	6	5	5	92.61	Inhibition	'='	%	1.0	CHEMBL1252445	Inhibition of JAK2 JH1 JH2 domain at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	single protein format
CHEMBL405042	0.0	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21	G2 inactive	External	329.38	3	4	3	3	2	101.29	Inhibition	'='	%	-0.15	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
CHEMBL476259	0.0	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1	G2 inactive	External	517.61	4	7	9	5	4	121.19	Inhibition	'='	%	1.78	CHEMBL1962118	GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn]	single protein format
